ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1705

Reduced DNASE1L3 Activity and Increased Anti-NET Protective Antibodies Contributes to Accumulation of Neutrophil Extracellular Traps in Pediatric SLE Patients

Betsy Barnes1, Lydia Thomas2, Jenna Battaglia Battaglia3, Kim Simpfendorfer3, Joyce Hui-Yuen4, Vinay Sharma5 and Bharati Matta6, 1Northwell Health, Manhasset, NY, 2Northwell Health - Cohen Children's Medical Center, Lake Success, NY, 3Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, 4North Shore LIJ Health System, Great Neck, NY, 5Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India, 6The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY and Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, NY

Meeting: ACR Convergence 2023

Keywords: Lupus nephritis, neutrophils, Pediatric rheumatology, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1705–1712) Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Pediatric systemic lupus erythematosus (pSLE) is a multisystemic chronic autoimmune disease with high renal involvement. In SLE, neutrophil extracellular traps (NETs) are considered a potential source of antigen, leading to autoantibody production. NETs activate plasmacytoid dendritic cells to produce high levels of interferon-α, a known driver of lupus pathogenesis. NETs have also been shown to play a role in kidney pathology leading to lupus nephritis (LN).Also, low DNase activity and mutations in DNASEIL3 have been associated with lupus. We hypothesized that NETs will be elevated in pediatric lupus and our study aims to investigate levels of circulating NETs in pSLE as compared to healthy children (pHC) and further elucidate mechanisms contributing to NET accumulation.

Methods: Plasma was obtained from 13 pSLE patients who were either treatment-naïve or not on corticosteroids at the time of enrollment and 12 pHC. Lupus disease activity was measured using SELENA-SLEDAI. ELISA and smear assay were used to detect NETs in plasma samples. DNASE1L3 concentration was measured using ELISA and DNase1L3 enzymatic activity was assayed by digestion of chromatin in purified nuclei. The ability of plasma to degrade NETs was measured using NET degradation assay.

Results: 10/13 of pSLE patients were female, with a mean of 13±4.4years, and a mean SLEDAI score of 13.8±8.1. 7/13 patients had biopsy-proven proliferative LN. Significantly higher levels of circulating NETs were found in pSLE plasma which positively correlated with measures of disease activity and anti-ds DNA titers (Figure 1). Plasma from pSLE failed to degrade NETs efficiently. Although DNASE1L3 levels were higher in pSLE patients, DNASE1L3 activity was reduced, as compared to healthy children. Moreover, higher anti-NET protective antibodies were found in pSLE plasma.

Conclusion: These data suggest that defective functional DNASE1L3 activity and increased anti-NET protective antibodies could lead to delayed clearance and accumulation of NETs in pSLE plasma.

Supporting image 1


Disclosures: B. Barnes: None; L. Thomas: None; J. Battaglia: None; K. Simpfendorfer: None; J. Hui-Yuen: None; V. Sharma: None; B. Matta: None.

To cite this abstract in AMA style:

Barnes B, Thomas L, Battaglia J, Simpfendorfer K, Hui-Yuen J, Sharma V, Matta B. Reduced DNASE1L3 Activity and Increased Anti-NET Protective Antibodies Contributes to Accumulation of Neutrophil Extracellular Traps in Pediatric SLE Patients [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/reduced-dnase1l3-activity-and-increased-anti-net-protective-antibodies-contributes-to-accumulation-of-neutrophil-extracellular-traps-in-pediatric-sle-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reduced-dnase1l3-activity-and-increased-anti-net-protective-antibodies-contributes-to-accumulation-of-neutrophil-extracellular-traps-in-pediatric-sle-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology